The store will not work correctly when cookies are disabled.
8-chloro-6-(4-chlorophenyl)-1-methyl-3,4-dihydrobenzo[b][1,5]diazocin-2(1H)-one
ID: ALA4088018
PubChem CID: 16457178
Max Phase: Preclinical
Molecular Formula: C17H14Cl2N2O
Molecular Weight: 333.22
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN1C(=O)CC/N=C(/c2ccc(Cl)cc2)c2cc(Cl)ccc21
Standard InChI: InChI=1S/C17H14Cl2N2O/c1-21-15-7-6-13(19)10-14(15)17(20-9-8-16(21)22)11-2-4-12(18)5-3-11/h2-7,10H,8-9H2,1H3/b20-17-
Standard InChI Key: RYFVPWCSBPISQS-JZJYNLBNSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
14.4560 -10.3143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7431 -11.0812 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5637 -11.1057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1208 -11.7044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0922 -12.5209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4977 -13.0780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6770 -13.0535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3389 -13.7972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8162 -14.4614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4780 -15.2052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6667 -15.2847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3286 -16.0285 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13.1895 -14.6205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5276 -13.8768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8977 -10.3620 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1486 -11.6383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1199 -12.4548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3992 -12.8399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7071 -12.4085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9863 -12.7936 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
12.7316 -11.5920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4523 -11.2069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
11 13 1 0
13 14 2 0
8 14 1 0
3 15 2 0
2 16 1 0
16 17 2 0
7 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
19 21 1 0
21 22 2 0
16 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 333.22 | Molecular Weight (Monoisotopic): 332.0483 | AlogP: 4.20 | #Rotatable Bonds: 1 |
Polar Surface Area: 32.67 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.86 | CX LogP: 3.92 | CX LogD: 3.92 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.77 | Np Likeness Score: -0.45 |
References
1. Ayoub AM, Hawk LML, Herzig RJ, Jiang J, Wisniewski AJ, Gee CT, Zhao P, Zhu JY, Berndt N, Offei-Addo NK, Scott TG, Qi J, Bradner JE, Ward TR, Schönbrunn E, Georg GI, Pomerantz WCK.. (2017) BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen., 60 (12): [PMID:28535045] [10.1021/acs.jmedchem.6b01336] |